Amendment of the Medicines for Human Use (Clinical Trials) Regulations 2004
This
adran has no associated
Memorandwm Esboniadol
58.—(1) The Medicines for Human Use (Clinical Trials) Regulations 2004(1) are amended as follows.
(2) In regulation—
(a)17(2)(b)(ii) (request for authorisation to conduct a clinical trial),
(b)24(10) (amendments by the sponsor),
(c)38(3)(b) (application for manufacturing authorisation),
(d)44(8) (variation of manufacturing authorisation),
for “Medicines (Products for Human Use) (Fees) Regulations 2012” substitute “Medicines (Products for Human Use) (Fees) Regulations 2013”.
(1)
S.I. 2004/1031; relevant amendments are made by S.I. 2006/1928, 2012/504.